News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
PharmaFrontiers Appoints David B. McWilliams CEO; Brian E. Rodriguez Named Director, Head Of Audit Committee
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Adult stem cell therapy developer PharmaFrontiers Corp. (OTCBB:PFTR) has appointed David B. McWilliams as the company's chief executive officer.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Mergers & acquisitions
Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly
April 29, 2026
·
2 min read
·
Gabrielle Masson
Earnings
AstraZeneca bullish on $80B sales goal after beating expectations, Phase 3 data wins
April 29, 2026
·
2 min read
·
Nick Paul Taylor
Earnings
GSK’s Shingrix strategy shift drives sales beat even as vaccines slow
April 29, 2026
·
2 min read
·
Tristan Manalac
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
April 29, 2026
·
2 min read
·
Nick Paul Taylor